Friedberg Ezra M — SEC Form 4 filings
SEC reporting owner CIK 1679440. 12 Form 4 filings on record with FilingPulse; latest filed 2026-07-07.
Transaction summary — filings shown
Covers all 12 filings on record, filed 2024-02-23 to 2026-07-07. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): 1 leg across 1 filing — 16,667 shares, $100,002 total (shares × price as filed).
- Open-market sales (code S, non-derivative): 10 legs across 4 filings — 11,399 shares, $314,232 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 18.
- Largest priced transaction: sale of 5,999 shares @ $28.00 ($167,972) in Pelthos Therapeutics Inc., filed 2025-11-26.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Pelthos Therapeutics Inc. (PTHS) | Director | 12 | 1 leg · 16,667 sh · $100,002 | 10 legs · 11,399 sh · $314,232 | 18 |
Form 4 filings — Friedberg Ezra M
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-07-07 | 4 | Pelthos Therapeutics Inc. (PTHS) | Sale (S): 534 @ $26.03 · Sale (S): 24 @ $27.33 | EDGAR |
| 2026-06-17 | 4 | Pelthos Therapeutics Inc. (PTHS) | Sale (S): 224 @ $27.12 · Sale (S): 59 @ $27.94 | EDGAR |
| 2026-05-18 | 4 | Pelthos Therapeutics Inc. (PTHS) | Tax withholding (F): 144 @ $27.01 | EDGAR |
| 2026-04-06 | 4 | Pelthos Therapeutics Inc. (PTHS) | Sale (S): 293 @ $20.51 · Sale (S): 265 @ $21.36 | EDGAR |
| 2026-04-01 | 4/A | Pelthos Therapeutics Inc. (PTHS) | Grant/award (A): 6,450 @ $0 · Grant/award (A): 2,454 @ $0 · Grant/award (A): 19,108 @ $0 | EDGAR |
| 2025-11-26 | 4 | Pelthos Therapeutics Inc. (PTHS) | Sale (S): 5,999 @ $28 · Sale (S): 2,000 @ $28.14 · Sale (S): 1 @ $28.50 · Sale (S): 2,000 @ $28.00 | EDGAR |
| 2025-07-07 | 4 | Pelthos Therapeutics Inc. (PTHS) | Grant/award (A): 19,108 (derivative) · Grant/award (A): 58,230 (derivative) | EDGAR |
| 2025-07-03 | 4 | Pelthos Therapeutics Inc. (PTHS) | Conversion (C): 40,000 @ $10 · Conversion (C): 40,000 @ $10 · Purchase (P): 40,000 (derivative) @ $0 · Purchase (P): 40,000 (derivative) @ $0 · Conversion (C): 40,000 (derivative) @ $0 · Conversion (C): 40,000 (derivative) @ $0 | EDGAR |
| 2024-11-15 | 4 | Chromocell Therapeutics Corp (CHRO) | Grant/award (A): 24,533 (derivative) | EDGAR |
| 2024-06-18 | 4 | Chromocell Therapeutics Corp (CHRO) | Grant/award (A): 64,498 (derivative) | EDGAR |
| 2024-03-12 | 4/A | Chromocell Therapeutics Corp (CHRO) | Purchase (P): 16,667 @ $6 | EDGAR |
| 2024-02-23 | 4 | Chromocell Therapeutics Corp (CHRO) | Option exercise (M): 13,649 @ $4.80 · Option exercise (M): 6,992 @ $4.80 · Conversion (C): 65,513.61 (derivative) · Conversion (C): 33,136 (derivative) | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1679440 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →